2002
DOI: 10.1172/jci0216309
|View full text |Cite
|
Sign up to set email alerts
|

Cholic acid mediates negative feedback regulation of bile acid synthesis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

19
152
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 216 publications
(176 citation statements)
references
References 47 publications
19
152
0
Order By: Relevance
“…SHP mRNA levels were significantly increased with the synthetic FXR agonist GW4064, whereas an increase of ϳ2-fold was seen with CDCA compared with vehicle-treated cells (Fig. 1A) consistent with studies indicating that CDCA is a weak activator of SHP in vivo (20). BSEP mRNA levels were also induced by GW4064, and a 2-fold induction was seen with CDCA ( Fig.…”
Section: Identification Of Bat As a Fxr Targetsupporting
confidence: 87%
“…SHP mRNA levels were significantly increased with the synthetic FXR agonist GW4064, whereas an increase of ϳ2-fold was seen with CDCA compared with vehicle-treated cells (Fig. 1A) consistent with studies indicating that CDCA is a weak activator of SHP in vivo (20). BSEP mRNA levels were also induced by GW4064, and a 2-fold induction was seen with CDCA ( Fig.…”
Section: Identification Of Bat As a Fxr Targetsupporting
confidence: 87%
“…Ibabp mRNA expression is upregulated by bile acids via FXR (12,13,19,20) and was used as a positive control for the cholic acid feeding. Ibabp expression increased in the ileum, cecum, and proximal colon of cholic acid-fed mice (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The expression level of Cyp8b1, which is an important enzyme to determine cholic acid/chenodeoxycholic acid ratio (Bjorkhem & Eggertsen 2001, Li-Hawkins et al 2002, was significantly increased by 81% in male homozygous mice compared with that of the wild-type mice, while the others remained unchanged in male homozygous mice (Fig. 4A).…”
Section: Targeted Disruption Of the Gpbar1 Genementioning
confidence: 99%